AGL 38.18 Decreased By ▼ -0.22 (-0.57%)
AIRLINK 142.98 Increased By ▲ 7.98 (5.91%)
BOP 5.07 Decreased By ▼ -0.02 (-0.39%)
CNERGY 3.77 Decreased By ▼ -0.02 (-0.53%)
DCL 7.56 Decreased By ▼ -0.03 (-0.4%)
DFML 44.48 Increased By ▲ 0.03 (0.07%)
DGKC 76.25 Decreased By ▼ -1.15 (-1.49%)
FCCL 26.95 Increased By ▲ 0.07 (0.26%)
FFBL 52.00 Decreased By ▼ -0.97 (-1.83%)
FFL 8.52 Decreased By ▼ -0.02 (-0.23%)
HUBC 125.51 Increased By ▲ 1.71 (1.38%)
HUMNL 9.99 Increased By ▲ 0.05 (0.5%)
KEL 3.74 Increased By ▲ 0.01 (0.27%)
KOSM 8.15 Increased By ▲ 0.07 (0.87%)
MLCF 34.75 Increased By ▲ 1.05 (3.12%)
NBP 58.71 Increased By ▲ 0.22 (0.38%)
OGDC 154.50 Increased By ▲ 4.55 (3.03%)
PAEL 25.15 Increased By ▲ 0.45 (1.82%)
PIBTL 5.93 Increased By ▲ 0.08 (1.37%)
PPL 118.31 Increased By ▲ 6.66 (5.97%)
PRL 24.38 Increased By ▲ 0.48 (2.01%)
PTC 12.00 Decreased By ▼ -0.10 (-0.83%)
SEARL 56.00 Decreased By ▼ -0.89 (-1.56%)
TELE 7.05 Increased By ▲ 0.05 (0.71%)
TOMCL 34.99 Decreased By ▼ -0.16 (-0.46%)
TPLP 6.98 Decreased By ▼ -0.07 (-0.99%)
TREET 13.98 Decreased By ▼ -0.18 (-1.27%)
TRG 46.10 Decreased By ▼ -0.13 (-0.28%)
UNITY 26.00 Decreased By ▼ -0.08 (-0.31%)
WTL 1.21 No Change ▼ 0.00 (0%)
BR100 8,822 Increased By 86.7 (0.99%)
BR30 26,723 Increased By 466.7 (1.78%)
KSE100 83,532 Increased By 810.2 (0.98%)
KSE30 26,710 Increased By 328 (1.24%)

A South Korean court Monday imposed a suspended prison term on a disgraced scientist whose claims of stem-cell breakthroughs rocked the scientific world until his research was found to be faked. The Seoul court passed a two-year sentence suspended for three years on Hwang Woo-Suk after convicting him of embezzling research funds and of ethical lapses in obtaining human eggs for experiments.
It found him not guilty of defrauding private entities that contributed funds to his research. Prosecutors had demanded a four-year jail term for Hwang, who went on trial in June 2006, and said they would appeal the ruling that he is not guilty of fraud. Judges said he had known that his team "exaggerated or manipulated" some experiments, although they found no evidence he directly instructed them to do so.
The 56-year-old Hwang, who was impassive as the verdict was read, still retains a loyal following. He later smiled and shook hands with supporters inside the courtroom who clapped and shouted "Doctor Hwang, cheer up!" Another crowd of about 100 supporters outside applauded Hwang as he walked out through a crowd of journalists. The court received petitions from 55 lawmakers and others calling for leniency.
The scientist said his lawyers would decide whether to appeal. Hwang shot to fame in 2004 when he published a paper in the US journal "Science" claiming to have created the world's first stem-cell line from a cloned human embryo. In a follow-up paper in 2005 in the same journal, he maintained that his team had developed 11 patient-specific embryonic stem-cell lines. The claims raised hopes of new treatments for diseases such as cancer, diabetes and Parkinson's.
The government showered Hwang and his team from the prestigious Seoul National University (SNU) with money and honours. Hwang was awarded the title of "Supreme Scientist". But his reputation was tarnished in November 2005 by allegations that he had violated medical ethics by accepting human eggs from his own researchers.
Hwang apologised for the lapse but the scandal widened with reports from local television network MBC that his entire research was fabricated. In January 2006 an SNU investigative team ruled in a report that his findings were faked and said he had produced no stem cells of any kind.
Hwang was also found guilty of breaching a law on bioethics which bans illegal human egg transactions. "Hwang and his team failed to prove that they were not involved in illegal trading of human eggs," the verdict said. The judges said Hwang had misappropriated a combined 830 million won (704,000 dollars) in research funds by using borrowed bank accounts or manipulating tax bills. But they said he did not do so for personal profit.

Copyright Agence France-Presse, 2009

Comments

Comments are closed.